Development of a symptom-based severity score anchored to health-related quality of life post-COVID-19 within the population-based EPILOC cohorts
Abstract
Purpose
Because simple symptom counts treat all symptoms as equally important and may not adequately capture the HRQoL impact of...
Deep learning survival analysis with time-varying covariates: extending PyCox to assess COVID-19 antiviral treatments and long-COVID associations
Abstract
Objectives
To extend the PyCox to accommodate time-varying covariates using counting process data, addressing immortal time bias in...
Progressive Post-Acute Gut Microbiome Disruption Following SARS‑CoV‑2 Infection in Mice
Abstract
SARS‑CoV‑2 infection is increasingly recognized to produce long‑lasting physiological disturbances that extend beyond the acute phase. The gut microbiome has emerged as a potential contributor to...
3 Cardiac SARS-CoV-2 Viral Persistence in Decedents with Long COVID Manifesting Cardiac Symptoms: A Multi-Institutional Study from the RECOVER Program Autopsy Cohort
Background
SARS-CoV-2 RNA can persist in tissues long after initial infection, but with unclear significance. After acute...
https://www.publicsource.org/pots-long-covid-navigating-invisible-illnesses/
1800-word article.
I look fine, but dealing with chronic illness is my full-time job
My illnesses don’t show up on lab tests, nor do they affect my appearance. Some people think this makes them less real, but a few...
GeoMx DSP enables layer-specific spatial transcriptomic profiling of the human retina: A proof-of-concept study from post-COVID-19 donor tissue
Abstract
Purpose
To generate layer resolved spatial transcriptomic profiles of the human retina using NanoString GeoMx Digital Spatial Profiler (DSP)...
ACE2 dysregulation and lipid metabolism: Mechanistic interplay between COVID-19 and neurodegeneration
Abstract
Angiotensin-converting enzyme 2 (ACE2) is the primary cellular receptor of SARS-CoV-2. It is a key regulator of the renin-angiotensin system (RAS) and modulates blood pressure and...
Association of mRNA SARS-CoV-2 vaccination with fatigue and functional recovery in patients with post-acute sequelae of COVID-19 (PASC)
Background
Patients with post-acute sequelae of SARS-CoV-2 (PASC) fear SARS-CoV-2 vaccine-linked symptom aggravation. Data on objective functional outcomes...
Depression, but Not Fatigue, Improves as Part of Multimodal Post-COVID Rehabilitation
Abstract
Introduction: Post-COVID syndrome (PCS) can lead to severe restrictions in the ability to work and participate in society and can lead to the development of depressive symptoms.
The aim of this...
Healthcare utilization patterns and medication burden in post-COVID syndrome: a cross-sectional analysis reveals four phenotypes
Abstract
Post-COVID syndrome has emerged as a major public health challenge, yet comprehensive characterization of healthcare utilization patterns and medication...
Pacing and Patching: Körpertherapie mit funktioneller Entspannung bei Post-COVID, 2026, Betker et al.
Abstract (Machine Translation)
Post-COVID syndrome (PCS) encompasses far more than persistent fatigue (ME/CFS).
Sensitivity to noise and light, cognitive impairments (“brain fog”), and...
Das Post-COVID-Syndrom – Überblick über bio-psycho-soziale Erklärungsmodelle
Kupferschmitt, Alexa A.; Köllner, Volker
Abstract
The most common symptoms of post-COVID-19 syndrome (PCS) include fatigue, cognitive impairment and pain.
These persistent symptoms impair the ability to perform and...
Einfluss dysfunktionaler Schon- und Durchhaltemuster auf die Aufrechterhaltung von Post-COVID Fatigue?
Abstract
Background
Following a SARS-CoV-2 infection, around 10% of patients develop post-COVID symptoms, with fatigue being one of the most common symptoms. This leads to a considerable...
Bewegungstherapie beim Post-COVID-Syndrom – Umsetzung in der Rehabilitation
Abstract
Approximately 1–2% of all those affected by COVID-19 will develop post-COVID syndrome (PCS) to the extent that their ability to work is compromised and they require rehabilitation.
Evidence to date supports...
Cognitive fatigue is related to reduced cerebral perfusion and sustained attention in patients with post COVID-19 condition: An fMRI study
Hedberg, Sonia Miri; Borg, Kristian; Stenberg, Jonas; Hedström, Stina; Granberg, Tobias; Gyllenberg, Alexandra; Petersson, Sven; Van Loo, Hadrien; Nordin...
Elevated risk of first-time pulmonary hypertension among COVID-19 survivors: a 4.5-year longitudinal study
Abstract
Background
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection could result in pulmonary vascular injury, systemic inflammation, and endothelial dysfunction...
Potentials for improving the healthcare for young people with post-COVID-19 syndrome: Analysis of stakeholder workshops on the model project Post-COVID Kids Bavaria
Mara Linnea König 1 2 , Maja Pawellek 1 2 , Chiara Rathgeb 2 3 , Uta Behrends 4 , Michael Kabesch 1 2 , Christian...
Post-acute symptom persistence following SARS-CoV-2, RSV, and influenza in children
Bedir, Firat; Demir, Velit
Abstract
Persistent symptoms following acute viral respiratory infections are increasingly recognized in children.
While post-acute sequelae of severe acute respiratory syndrome...
Post copied from News from the USA
The Department of Defense has "announced the approval of a clinical trial award of up to $13.1 million from the U.S. Department of Defense (DOD) to evaluate Bezisterim (NE3107) for treating neurological symptoms associated with long COVID." The funding is...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.